Filter immunocytology: Methodologic evaluation of a new assay for the diagnosis of urothelial cancer

Acta Cytologica

Volumn 40, Issue 2, 1996, Pages 269-276

  Schmitz Dräger, Bernd J ^a   Strich, Wolfgang E ^a   Gerke, Roger ^a   Decken, Klaus ^a   Ebert, Thomas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bladder neoplasms; Filter immunocytology

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TECHNIQUE;

EID: 0029987075     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333750     Document Type: Article

References (14)

1. Chicheportiche C, Gazarossian E, Longin A, Lebreuil G, Her-manowicz M, Richaud C, Beley S, Kaphan S, Fontaniere B, Cotte G, Laurent J-C: Combination of standard cytology and immunocytology with BL 2-10D1 monoclonal antibody for monitoring treated bladder cancer patients. Eur Urol 1993; 23:405-408
2. Decken K, Schmitz-Dräger BJ, Rohde D, Nakamura S, Ebert T, Ackermann R: Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma: I. Production, specificity analysis and preliminary characterization of the antigen. J Urol 1993;147:235-241
3. Gerke R, Decken K, Strich WE, Ebert T, Schmitz-Dräger BJ: Filterimmunocytology (FLIC): A novel diagnostic assay for detection of urothelial carcinoma (submitted for publication)
4. Huland E, Huland H, Arndt R, Baisch H, Klöppel G: Urindiagnostik oberflächlicher Harnblasentumoren durch Zytologie, Immunzytologie und Flowzytometrie: Ergebnisse einer prospektiven vergleichenden Studie an 104 Patienten. Akt Urol 1993;19:13-17
5. Huland H, Arndt R, Huland E, Loening TE, Steffens M: Monoclonal antibody 486 P 3/12: A valuable bladder carcinoma marker for immunocytology. J Urol 1987;137:654-659
6. Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Dräger BJ: Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder. J Urol 1991;146:1631-1636
7. Huland E, Huland H, Schneider AW: Quantitative immuno-cytology in the management of patients with superficial bladder carcinoma: I. A marker to identify patients who do not require prophylaxis. J Urol 1990;144:637-640
8. Klähn R, Huland E, Baisch H, Huland H: Sensitivity of urinary quantitative immunocytology with monoclonal antibody 486 P3/12 in 241 unselected patients with bladder carcinoma. J Urol 1991;145:495-497
9. Longin A, Fontaniere B, Berger-Dutrieux N, Devonec M, Laurent J-C: A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology. Cancer 1990;65:1412-1417
10. Mostofi FK: Histological Typing of Urinary Bladder Tumours. Geneva, World Health Organization, 1973
11. Schmitz-Dräger BJ, Gerke R, Strich WE, Decken K, Ebert T: Filter-Immunzytologie (FLIC): Ein neuer Test zum Nach-weis antigener Veränderungen auf Urothelzellen. In Jahrbuch der Urologie. Edited by V Jonas. Zilpich, Germany, Biermann, 1994, pp 147-149
12. Schmitz-Dräger BJ, Nakamura S, Decken K, Pfitzer P, Rottmann-Ickler C, Ebert T, Ackermann R: Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma: II. Prospective trial on the diagnostic value of immuno-cytology using monoclonal antibody Due ABC 3. J Urol 1991;146:1521-1524
13. Schmitz-Dräger BJ, Rohde D, Peschkes C, Ebert T, Ackermann R: Monoklonale Antikörper gegen Harnblasenkarzinome: Ein Beitrag zur Verbesserung der Diagnostik? Akt Urol 1988;19:117-123
14. Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, So-gani PC, Herr HW, Whitmore WF, Cordon-Cardo C: Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol 1990;143:285-288